ORAOV1 anticorps
-
- Antigène Tous les produits ORAOV1
- ORAOV1 (Oral Cancer Overexpressed 1 (ORAOV1))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp ORAOV1 est non-conjugé
-
Application
- Western Blotting (WB), ELISA
- Purification
- Purified
- Immunogène
- ORAV1 antibody was raised in Rabbit using synthesized peptide derived from internal of human ORAV1 as the immunogen
- Isotype
- IgG
-
anti-Oral Cancer Overexpressed 1 (ORAOV1) (Internal Region) antibody
ORAOV1 Reactivité: Humain, Rat WB, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-Oral Cancer Overexpressed 1 (ORAOV1) (Center) antibodyORAOV1 Reactivité: Humain WB, IF, IHC, IC Hôte: Lapin Polyclonal unconjugated
anti-Oral Cancer Overexpressed 1 (ORAOV1) (Internal Region) antibodyORAOV1 Reactivité: Humain WB, ELISA, IF, IHC Hôte: Lapin Polyclonal unconjugated
anti-Oral Cancer Overexpressed 1 (ORAOV1) (AA 81-130) antibodyORAOV1 Reactivité: Humain WB, ELISA Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
- WB: 1:500-1:1000, ELISA: 1:10000
- Restrictions
- For Research Use only
-
- Concentration
- Lot specific
- Buffer
- PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles
- Stock
- -20 °C
- Stockage commentaire
- Store in small aliquots at -20 °C
-
- Antigène
- ORAOV1 (Oral Cancer Overexpressed 1 (ORAOV1))
- Autre désignation
- ORAV1 (ORAOV1 Produits)
- Synonymes
- anticorps TAOS1, anticorps 2210010N10Rik, anticorps oral cancer overexpressed 1, anticorps ORAOV1, anticorps Oraov1
-
